Nusinersen for Spinal Muscular Atrophy
What You Need to Know Before You Apply
What is the purpose of this trial?
This study is an open label individual patient study of the drug Nusinsersen.
Are You a Good Fit for This Trial?
This trial is for people with spinal muscular atrophy who have already taken part in a previous study using Nusinersen. Only those who meet specific medical requirements and do not have conditions that would make participation unsafe can join.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Nusinersen
Trial Overview
The study gives Nusinersen injections to one participant in an open-label format, meaning both doctors and the patient know what treatment is being given. The goal is to monitor safety and effects of continued use.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Open label
Find a Clinic Near You
Who Is Running the Clinical Trial?
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.